Derma Sciences (DSCI +2.6%) moves up after it's Q3 beats across the board on narrower losses....

|About: Derma Sciences Inc. (DSCI)|By:, SA News Editor

Derma Sciences (DSCI +2.6%) moves up after it's Q3 beats across the board on narrower losses. Total revenue jumped 24% Y/Y on a 67% increase in sales of its advanced wound care products and a 9% gain in traditional wound care. Better cost controls gave gross margins a big boost, gaining 5 percentage points to 35.2% from 30.0% during the prior-year period.